Primary biliary cirrhosis

Best Practice and Research: Clinical Gastroenterology

Volumn 24, Issue 5, 2010, Pages 647-654

  Nguyen, Douglas L ^a   Juran, Brian D ^a   Lazaridis, Konstantinos N ^a  

^a MAYO CLINIC   (United States)

Author keywords

Bile ducts; Cholestasis; Genetics; Natural history

Indexed keywords

ALKALINE PHOSPHATASE; AZATHIOPRINE; BEZAFIBRATE; COLCHICINE; METHOTREXATE; MITOCHONDRION ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; SILYMARIN; URSODEOXYCHOLIC ACID;

ADJUVANT THERAPY; ANAMNESIS; BIOCHEMISTRY; CHOLESTATIC HEPATITIS; CLINICAL FEATURE; DISEASE DURATION; DRUG EFFICACY; ENVIRONMENTAL EXPOSURE; FOOD AND DRUG ADMINISTRATION; HEREDITY; HISTOPATHOLOGY; HUMAN; INCIDENCE; LIVER BIOPSY; LIVER TRANSPLANTATION; NONHUMAN; OSTEOPOROSIS; PREVALENCE; PRIMARY BILIARY CIRRHOSIS; REVIEW; RISK ASSESSMENT; TREATMENT RESPONSE;

EID: 77958105177     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2010.07.006     Document Type: Article

References (66)

1. S.J. Yeaman, J.A. Kirby, and D.E. Jones Autoreactive responses to pyruvate dehydrogenase complex in the pathogenesis of primary biliary cirrhosis Immunol Rev 174 2000 Apr 238 249
2. S. Terasaki, Y. Nakanuma, M. Yamazaki, and M. Unoura Eosinophilic infiltration of the liver in primary biliary cirrhosis: a morphological study Hepatology (Baltimore, Md.) 17 2 1993 Feb 206 212
3. S. Hohenester, R.P. Oude-Elferink, and U. Beuers Primary biliary cirrhosis Semin Immunopathol 31 3 2009 Sep 283 307
4. E.H. Ahrens Jr., and H.G. Kunkel The relationship between serum lipids and skin xanthomata in 18 patients with primary biliary cirrhosis J Clin Invest 28 6, Pt. 2 1949 Nov 1565 1574
5. P.M. Huet, J. Deslauriers, A. Tran, C. Faucher, and J. Charbonneau Impact of fatigue on the quality of life of patients with primary biliary cirrhosis Am J Gastroenterology 95 3 2000 Mar 760 767
6. N.V. Bergasa The pruritus of cholestasis J Hepatology 43 6 2005 Dec 1078 1088
7. M.E. Gershwin, and I.R. Mackay The causes of primary biliary cirrhosis: Convenient and inconvenient truths Hepatology (Baltimore, Md) 47 2 2008 Feb 737 745
8. K.N. Lazaridis, and J.A. Talwalkar Clinical epidemiology of primary biliary cirrhosis: incidence, prevalence, and impact of therapy J Clin Gastroenterol 41 5 2007 May Jun 494 500
9. A.N. Hamlyn, and S. Sherlock The epidemiology of primary biliary cirrhosis: a survey of mortality in England and Wales Gut 15 6 1974 Jun 473 479
10. A.N. Hamlyn, A.F. Macklon, and O. James Primary biliary cirrhosis: geographical clustering and symptomatic onset seasonality Gut 24 10 1983 Oct 940 945
11. V. Balakrishnan, and A.S. Bhaskaran Primary biliary cirrhosis with pruritus in India Indian J Gastroenterol 16 3 1997 Jul 121 122
12. K.M. Boberg, E. Aadland, J. Jahnsen, N. Raknerud, M. Stiris, and H. Bell Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population Scand J Gastroenterol 33 1 1998 Jan 99 103
13. W.R. Kim, K.D. Lindor, G.R. Locke 3rd, T.M. Therneau, H.A. Homburger, and K.P. Batts Epidemiology and natural history of primary biliary cirrhosis in a US community Gastroenterology 119 6 2000 Dec 1631 1636
14. D. Ray-Chadhuri, E. Rigney, and K. McComack Epidemiology of PBC in Sheffield updated: Demographics and Relation to Water Supply 2001 British Association for the Study of the Liver London 42
15. K.J. Hurlburt, B.J. McMahon, H. Deubner, B. Hsu-Trawinski, J.L. Williams, and K.V. Kowdley Prevalence of autoimmune liver disease in Alaska Natives Am J Gastroenterology 97 9 2002 Sep 2402 2407
16. S. Sood, P.J. Gow, J.M. Christie, and P.W. Angus Epidemiology of primary biliary cirrhosis in Victoria, Australia: high prevalence in migrant populations Gastroenterology 127 2 2004 Aug 470 475
17. M.E. Gershwin, M. Rowley, P.A. Davis, P. Leung, R. Coppel, and I.R. Mackay Molecular biology of the 2-oxo-acid dehydrogenase complexes and anti-mitochondrial antibodies Prog Liver Dis 10 1992 47 61
18. M.M. Kaplan, and M.E. Gershwin Primary biliary cirrhosis N Engl J Med 353 12 2005 Sep 22 1261 1273
19. J.M. Palmer, J.A. Kirby, and D.E. Jones The immunology of primary biliary cirrhosis: the end of the beginning? Clin Exp Immunol 129 2 2002 Aug 191 197
20. A. Lleo, C. Selmi, P. Invernizzi, M. Podda, R.L. Coppel, and I.R. Mackay Apotopes and the biliary specificity of primary biliary cirrhosis Hepatology (Baltimore, Md.) 49 3 2009 Mar 871 879
21. C. Selmi, M.J. Mayo, N. Bach, H. Ishibashi, P. Invernizzi, and R.G. Gish Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment Gastroenterology 127 2 2004 Aug 485 492
22. D.E. Jones, and P.T. Donaldson Genetic factors in the pathogenesis of primary biliary cirrhosis Clin Liver Disease 7 4 2003 Nov 841 864
23. B.D. Juran, and K.N. Lazaridis Genetics and genomics of primary biliary cirrhosis Clin Liver Disease 12 2 2008 May 349 365 [ix]
24. K.N. Lazaridis, B.D. Juran, G.M. Boe, J.P. Slusser, M. de Andrade, and H.A. Homburger Increased prevalence of antimitochondrial antibodies in first-degree relatives of patients with primary biliary cirrhosis Hepatology (Baltimore, Md.) 46 3 2007 Sep 785 792
25. P.T. Donaldson, A. Baragiotta, M.A. Heneghan, A. Floreani, C. Venturi, and J.A. Underhill HLA class II alleles, genotypes, haplotypes, and amino acids in primary biliary cirrhosis: a large-scale study Hepatology (Baltimore, Md.) 44 3 2006 Sep 667 674
26. S. Onishi, T. Sakamaki, T. Maeda, S. Iwamura, A. Tomita, and T. Saibara DNA typing of HLA class II genes; DRB1 (*)0803 increases the susceptibility of Japanese to primary biliary cirrhosis J Hepatology 21 6 1994 Dec 1053 1060
27. G.M. Hirschfield, X. Liu, C. Xu, Y. Lu, G. Xie, and Y. Lu Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants N Engl J Med 360 24 2009 Jun 11 2544 2555
28. A.G. Wilson, J.A. Symons, T.L. McDowell, H.O. McDevitt, and G.W. Duff Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation Proceedings of the National Academy of Sciences of the United States of America 94 7 1997 Apr 1 3195 3199
29. M.A. Gordon, E. Oppenheim, N.J. Camp, F.S. di Giovine, G.W. Duff, and D. Gleeson Primary biliary cirrhosis shows association with genetic polymorphism of tumour necrosis factor alpha promoter region J Hepatology 31 2 1999 Aug 242 247
30. D.E. Jones, O.F. James, B. Portmann, A.D. Burt, R. Williams, and M. Hudson Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis Hepatology (Baltimore, Md.) 30 1 1999 Jul 53 57
31. B.D. Juran, E.J. Atkinson, E.M. Schlicht, B.L. Fridley, G.M. Petersen, and K.N. Lazaridis Interacting alleles of the coinhibitory immunoreceptor genes cytotoxic T-lymphocyte antigen 4 and programmed cell-death 1 influence risk and features of primary biliary cirrhosis Hepatology (Baltimore, Md.) 47 2 2008 Feb 563 570
32. K. Agarwal, D.E. Jones, A.K. Daly, O.F. James, B. Vaidya, and S. Pearce CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis J Hepatology 32 4 2000 Apr 538 541
33. B.D. Juran, E.J. Atkinson, E.M. Schlicht, B.L. Fridley, and K.N. Lazaridis Primary biliary cirrhosis is associated with a genetic variant in the 3' flanking region of the CTLA4 gene Gastroenterology 135 4 2008 Oct 1200 1206
34. B. Zhong, P. Strnad, C. Selmi, P. Invernizzi, G.Z. Tao, and A. Caleffi Keratin variants are overrepresented in primary biliary cirrhosis and associate with disease severity Hepatology (Baltimore, Md.) 50 2 2009 Aug 546 554
35. M.I. Prince, A. Chetwynd, P. Diggle, M. Jarner, J.V. Metcalf, and O.F. James The geographical distribution of primary biliary cirrhosis in a well-defined cohort Hepatology (Baltimore, Md.) 34 6 2001 Dec 1083 1088
36. A. Ala, C.M. Stanca, M. Bu-Ghanim, I. Ahmado, A.D. Branch, and T.D. Schiano Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites Hepatology (Baltimore, Md.) 43 3 2006 Mar 525 531
37. C. Selmi, Y. Ichiki, P. Invernizzi, M. Podda, and M.E. Gershwin The enigma of primary biliary cirrhosis Clin Rev Allergy Immunol 28 2 2005 Apr 73 81
38. A. Parikh-Patel, E.B. Gold, H. Worman, K.E. Krivy, and M.E. Gershwin Risk factors for primary biliary cirrhosis in a cohort of patients from the united states Hepatology (Baltimore, Md.) 33 1 2001 Jan 16 21
39. M.E. Gershwin, C. Selmi, H.J. Worman, E.B. Gold, M. Watnik, and J. Utts Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients Hepatology (Baltimore, Md.) 42 5 2005 Nov 1194 1202
40. D. Howel, C.M. Fischbacher, R.S. Bhopal, J. Gray, J.V. Metcalf, and O.F. James An exploratory population-based case-control study of primary biliary cirrhosis Hepatology (Baltimore, Md.) 31 5 2000 May 1055 1060
41. K.D. Lindor, M.E. Gershwin, R. Poupon, M. Kaplan, N.V. Bergasa, and E.J. Heathcote Primary biliary cirrhosis Hepatology (Baltimore, Md.) 50 1 2009 Jul 291 308
42. J.A. Talwalkar, and K.D. Lindor Primary biliary cirrhosis Lancet 362 9377 2003 Jul 5 53 61
43. J.L. Newton, G.J. Gibson, M. Tomlinson, K. Wilton, and D. Jones Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence Hepatology (Baltimore, Md.) 44 1 2006 Jul 91 98
44. N.V. Bergasa, A. Mason, A. Floreani, J. Heathcote, M.G. Swain, and D.E. Jones Primary biliary cirrhosis: report of a focus study group Hepatology (Baltimore, Md.) 40 4 2004 Oct 1013 1020
45. E. van Os, W.W. van den Broek, P.G. Mulder, P.C. ter Borg, J.A. Bruijn, and H.R. van Buuren Depression in patients with primary biliary cirrhosis and primary sclerosing cholangitis J Hepatology 46 6 2007 Jun 1099 1103
46. M.M. Kaplan, and P.A. Bonis Modafinil for the treatment of fatigue in primary biliary cirrhosis Ann Intern Med 143 7 2005 Oct 4 546 547
47. A. Pares, and N. Guanabens Osteoporosis in primary biliary cirrhosis: pathogenesis and treatment Clin Liver Disease 12 2 2008 May 407 424 [x]
48. J. Bruix, and M. Sherman Management of hepatocellular carcinoma Hepatology (Baltimore, Md.) 42 5 2005 Nov 1208 1236
49. M. Prince, A. Chetwynd, W. Newman, J.V. Metcalf, and O.F. James Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years Gastroenterology 123 4 2002 Oct 1044 1051
50. P. Angulo, K.P. Batts, T.M. Therneau, R.A. Jorgensen, E.R. Dickson, and K.D. Lindor Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis Hepatology (Baltimore, Md.) 29 3 1999 Mar 644 647 (Pubitemid 29109574)
51. K.D. Lindor, R.A. Jorgensen, T.M. Therneau, M. Malinchoc, and E.R. Dickson Ursodeoxycholic acid delays the onset of esophageal varices in primary biliary cirrhosis Mayo Clin Proc 72 12 1997 Dec 1137 1140
52. C. Corpechot, F. Carrat, A. Bahr, Y. Chretien, R.E. Poupon, and R. Poupon The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis Gastroenterology 128 2 2005 Feb 297 303
53. C. Corpechot, L. Abenavoli, N. Rabahi, Y. Chretien, T. Andreani, and C. Johanet Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis Hepatology (Baltimore, Md.) 48 3 2008 Sep 871 877
54. E.M. Kuiper, B.E. Hansen, R.A. de Vries, J.W. den Ouden-Muller, T.J. van Ditzhuijsen, and E.B. Haagsma Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid Gastroenterology 136 4 2009 Apr 1281 1287
55. J. Lee, A. Belanger, J.T. Doucette, C. Stanca, S. Friedman, and N. Bach Transplantation trends in primary biliary cirrhosis Clin Gastroenterol Hepatol 5 11 2007 Nov 1313 1315
56. K.N. Lazaridis, G.J. Gores, and K.D. Lindor Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders' J Hepatology 35 1 2001 Jul 134
57. R.E. Poupon, B. Balkau, E. Eschwege, and R. Poupon A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group N Engl J Med 324 22 1991 May 30 1548 1554
58. E.J. Heathcote, K. Cauch-Dudek, V. Walker, R.J. Bailey, L.M. Blendis, and C.N. Ghent The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis Hepatology (Baltimore, Md.) 19 5 1994 May 1149 1156
59. R.E. Poupon, K.D. Lindor, K. Cauch-Dudek, E.R. Dickson, R. Poupon, and E.J. Heathcote Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis Gastroenterology 113 3 1997 Sep 884 890
60. J. Goulis, G. Leandro, and A.K. Burroughs Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis Lancet 354 9184 1999 Sep 25 1053 1060
61. C. Gluud, and E. Christensen Ursodeoxycholic acid for primary biliary cirrhosis Cochrane Database Syst Rev 2002 (1):CD000551
62. R. Poupon, O. Chazouilleres, and R.E. Poupon Chronic cholestatic diseases J Hepatology 32 1 Suppl 2000 129 140
63. P. Angulo, E.R. Dickson, T.M. Therneau, R.A. Jorgensen, C. Smith, and C.K. DeSotel Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial J Hepatology 30 5 1999 May 830 835
64. C.N. Williams, B. Al-Knawy, and W. Blanchard Bioavailability of four ursodeoxycholic acid preparations Aliment Pharmacol Ther 14 9 2000 Sep 1133 1139
65. G.C. MacQuillan, and J. Neuberger Liver transplantation for primary biliary cirrhosis Clin Liver Disease 7 4 2003 Nov 941 956 [ix] (Pubitemid 37229512)
66. T.C. Schreuder, S.G. Hubscher, and J. Neuberger Autoimmune liver diseases and recurrence after orthotopic liver transplantation: what have we learned so far? Transpl Int 22 2 2009 Feb 144 152